Form 8-K - Current report:
SEC Accession No. 0001193125-16-423538
Filing Date
2016-01-07
Accepted
2016-01-07 16:36:00
Documents
8
Period of Report
2016-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d106844d8k.htm 8-K 22920
2 EX-1.1 d106844dex11.htm EX-1.1 166902
3 EX-4.1 d106844dex41.htm EX-4.1 130258
4 EX-5.1 d106844dex51.htm EX-5.1 6552
5 EX-99.1 d106844dex991.htm EX-99.1 7044
6 EX-99.2 d106844dex992.htm EX-99.2 7987
7 GRAPHIC g106844ex99_1pg001.jpg GRAPHIC 10121
8 GRAPHIC g106844ex99_1pg002.jpg GRAPHIC 10121
  Complete submission text file 0001193125-16-423538.txt   371317
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 161330573
SIC: 2834 Pharmaceutical Preparations